Latest news
Vera Therapeutics reports Q2 net loss of $109.5M as TRUTAKNA receives FDA accelerated approval - TradingViewTradingView · Mon, 10 Aug 2026 20:14:34 GMTVera Therapeutics (VERA) ramps spending ahead of TRUTAKNA launch and posts $230.5M loss - Stock TitanStock Titan · Mon, 10 Aug 2026 20:11:44 GMTVera Therapeutics Provides Business Update and Reports Second Quarter 2026 Financial Results - The Manila TimesThe Manila Times · Mon, 10 Aug 2026 20:09:31 GMT